Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	«FIRMA «SILICEA» LLC 2004-12-01
Σειρά:	Российский кардиологический журнал
Θέματα:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Διαθέσιμο Online:	https://russjcardiol.elpub.ru/jour/article/view/2326

Παρόμοια τεκμήρια

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
ανά: S. V. Nedogoda, κ.ά.
Έκδοση: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
ανά: P. P. Tikhonov, κ.ά.
Έκδοση: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
ανά: S. V. Nedogoda, κ.ά.
Έκδοση: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
ανά: S. I. Drozdetsky, κ.ά.
Έκδοση: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
ανά: A. P. Kondrakhin, κ.ά.
Έκδοση: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
ανά: E. V. Eliseeva, κ.ά.
Έκδοση: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
ανά: Y. R. Kasherininov, κ.ά.
Έκδοση: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
ανά: Mehmet Burak Yalçın, κ.ά.
Έκδοση: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
ανά: Osman Kukula, κ.ά.
Έκδοση: (2024-02-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
ανά: Nirma D. Perera, κ.ά.
Έκδοση: (2021-07-01)

Main results of the Russian trial «ALTAIR»
ανά: E. V. Shlyakhto, κ.ά.
Έκδοση: (2006-02-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
ανά: N. N. Nikitina, κ.ά.
Έκδοση: (2015-12-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
ανά: Monique L Parkin, κ.ά.
Έκδοση: (2016-11-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
ανά: V. Estato, κ.ά.
Έκδοση: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
ανά: L. A. Khaisheva, κ.ά.
Έκδοση: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
ανά: V. I. Makolkin
Έκδοση: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
ανά: András Érszegi, κ.ά.
Έκδοση: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
ανά: L. I. Markova, κ.ά.
Έκδοση: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
ανά: V. A. Nevzorova, κ.ά.
Έκδοση: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
ανά: I. E. Chazova, κ.ά.
Έκδοση: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
ανά: I. N. Medvedev, κ.ά.
Έκδοση: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
ανά: I. N. Medvedev, κ.ά.
Έκδοση: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
ανά: I. N. Medvedev, κ.ά.
Έκδοση: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
ανά: I. N. Medvedev, κ.ά.
Έκδοση: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
ανά: A. P. Vasilyev, κ.ά.
Έκδοση: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
ανά: A. N. Britov, κ.ά.
Έκδοση: (2006-06-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
ανά: E. G. Ivanova, κ.ά.
Έκδοση: (2023-04-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
ανά: N. J. Gromnazky, κ.ά.
Έκδοση: (2003-12-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
ανά: G. N. Gorokhovskaya, κ.ά.
Έκδοση: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
ανά: L. I. Abasova, κ.ά.
Έκδοση: (2011-08-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
ανά: E. G. Ivanova, κ.ά.
Έκδοση: (2022-07-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
ανά: M. M. Beraya, κ.ά.
Έκδοση: (2007-02-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
ανά: A S Ryazanov, κ.ά.
Έκδοση: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
ανά: M. M. Beraya, κ.ά.
Έκδοση: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
ανά: E. V. Tishina, κ.ά.
Έκδοση: (2011-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
ανά: V. V. Trusov, κ.ά.
Έκδοση: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
ανά: Roman A. Yaskevich, κ.ά.
Έκδοση: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
ανά: Roman A. Yaskevich, κ.ά.
Έκδοση: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
ανά: I. S. Dzherieva, κ.ά.
Έκδοση: (2015-12-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
ανά: Michał Łata, κ.ά.
Έκδοση: (2025-01-01)